Iptakalim inhibits nicotinic acetylcholine receptor-mediated currents in dopamine neurons acutely dissociated from rat substantia nigra pars compacta

Neuroscience Letters

Volumn 403, Issue 1-2, 2006, Pages 57-62

  Hu, J ^a,b   DeChon, J ^b   Yan, K C ^b   Liu, Q ^b   Hu, G ^a   Wu, J ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Dopaminergic neuron; Iptakalim; Nicotinic acetylcholine receptor; Patch clamp; Substantia nigra compacta

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ATROPINE; CHOLINERGIC RECEPTOR; GLUTAMATE RECEPTOR; IPTAKALIM; N METHYL 4 (3 PYRIDINYL) 3 BUTENAMINE; NEUROTRANSMITTER; NICOTINIC AGENT; NICOTINIC RECEPTOR; POTASSIUM CHANNEL;

AGONIST; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC RECEPTOR BLOCKING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROTRANSMISSION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TUBE; VOLTAGE CLAMP; WHOLE CELL;

ACETYLCHOLINE; ACTION POTENTIALS; ANIMALS; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MEMBRANE POTENTIALS; N-METHYLASPARTATE; NEURONS; NEUROTRANSMITTER AGENTS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PATCH-CLAMP TECHNIQUES; PROPYLAMINES; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC; SUBSTANTIA NIGRA;

EID: 33745501748     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.04.060     Document Type: Article

References (22)

1. Buisson B., and Bertrand D. Chronic exposure to nicotine upregulates the human (alpha)4(beta)2 nicotinic acetylcholine receptor function. J. Neurosci. 21 (2001) 1819-1829
2. Fenster C.P., Whitworth T.L., Sheffield E.B., Quick M.W., and Lester R.A. Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine. J. Neurosci. 19 (1999) 4804-4814
3. Gentry C.L., and Lukas R.J. Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr. Drug Targets. CNS. Neurol. Disord. 1 (2002) 359-385
4. Hu J., Lindenberger K., Hu G., Wang H., Lukas R.J., and Wu J. Iptakalim as a human nicotinic acetylcholine receptor antagonist. J. Pharmacol. Exp. Ther. 316 (2006) 914-925
5. Jonnala R.R., and Buccafusco J.J. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. J. Neurosci. Res. 66 (2001) 565-572
6. Levin E.D., Mead T., Rezvani A.H., Rose J.E., Gallivan C., and Gross R. The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats. Physiol. Behav. 71 (2000) 565-570
7. Liu Y., He H.R., Ding J.H., Gu B., Wang H., and Hu G. Iptakalim inhibits cocaine challenge-induced enhancement of dopamine levels in nucleus accumbens and striatum of rats by up-regulating Kir6.1 and Kir6.2 mRNA expression. Acta Pharmacol. Sin. 24 (2003) 527-533
8. Q. Liu, Z. Li, J.H. Ding, S.Y. Liu, J. Wu, G. Hu, Iptakalim inhibits nicotine-induced enhancement of extracellular dopamine and glutamate levels in the nucleus accumbens of rats, Brain Res., in press.
9. Lopez-Hernandez G.Y., Sanchez-Padilla J., Ortiz-Acevedo A., Lizardi-Ortiz J., Salas-Vincenty J., Rojas L.V., and Lasalde-Dominicci J.A. Nicotine-induced up-regulation and desensitization of alpha4beta2 neuronal nicotinic receptors depend on subunit ratio. J. Biol. Chem. 279 (2004) 38007-38015
10. McCallum S.E., Caggiula A.R., Epstein L.H., Saylor S., Ploskina T., and Sved A.F. Mecamylamine blocks the development of tolerance to nicotine in rats: implications for the mechanisms of tolerance. Psychopharmacology (Berl) 141 (1999) 332-338
11. Wang H. ATP-sensitive potassium channel as a new target for development of antihypertensive drugs. Acta Pharmacol. Sin. 19 (1998) 257-267
12. Wang H., Long C.L., and Zhang Y.L. A new ATP-sensitive potassium channel opener reduces blood pressure and reverses cardiovascular remodeling in experimental hypertension. J. Pharmacol. Exp. Ther. 312 (2005) 1326-1333
13. Wang H., Zhang Y.L., Tang X.C., Feng H.S., and Hu G. Targeting ischemic stroke with a novel opener of ATP-sensitive potassium channels in the brain. Mol. Pharmacol. 66 (2004) 1160-1168
14. Wang S., Hu L.F., Yang Y., Ding J.H., and Hu G. Studies of ATP-sensitive potassium channels on 6-hydroxydopamine and haloperidol rat models of Parkinson's disease: implications for treating Parkinson's disease?. Neuropharmacology 48 (2005) 984-992
15. Wang S., Hu L.F., Zhang Y., Sun T., Sun Y.H., Liu S.Y., Ding J.H., Wu J., and Hu G. Effects of systemic administration of iptakalim on extracellular neurotransmitter levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats. Neuropsychopharmacology 31 (2006) 933-940
16. Wonnacott S. The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol. Sci. 11 (1990) 216-219
17. Wu J., Chan P., Schroeder K.M., Ellsworth K., and Partridge L.D. 1-Methyl-4-phenylpridinium (MPP+)-induced functional run-down of GABA(A) receptor-mediated currents in acutely dissociated dopaminergic neurons. J. Neurochem. 83 (2002) 87-99
18. Wu J., George A.A., Schroeder K.M., Xu L., Marxer-Miller S., Lucero L., and Lukas R.J. Electrophysiological, pharmacological, and molecular evidence for alpha7-nicotinic acetylcholine receptors in rat midbrain dopamine neurons. J. Pharmacol. Exp. Ther. 311 (2004) 80-91
19. Yang Y., Liu X., Ding J.H., Sun J., Long Y., Wang F., Yao H.H., and Hu G. Effects of iptakalim on rotenone-induced cytotoxicity and dopamine release from PC12 cells. Neurosci. Lett. 366 (2004) 53-57
20. Yang Y., Liu X., Long Y., Wang F., Ding J.H., Liu S.Y., Sun Y.H., Yao H.H., Wang H., Wu J., and Hu G. Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats. J. Neurosci. Res. 80 (2005) 442-449
21. Yang Y., Liu X., Long Y., Wang F., Ding J.H., Liu S.Y., Sun Y.H., Yao H.H., Wang H., Wu J., and Hu G. Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats. Int. J. Neuropsychopharmacol. 9 (2006) 51-61
22. Yang Y.L., Meng C.H., Ding J.H., He H.R., Ellsworth K., Wu J., and Hu G. Iptakalim hydrochloride protects cells against neurotoxin-induced glutamate transporter dysfunction in in vitro and in vivo models. Brain Res. 1049 (2005) 80-88